Elevated mazes as animal models of anxiety: effects of serotonergic agents
Open Access
- 1 March 2007
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 79 (1) , 71-85
Abstract
This article reviews reported results about the effects of drugs that act upon the serotonergic neurotransmission measured in three elevated mazes that are animal models of anxiety. A bibliographic search has been performed in MEDLINE using different combinations of the key words X-maze, plus-maze, T-maze, serotonin and 5-HT, present in the title and/or the abstract, with no time limit. From the obtained abstracts, several publications were excluded on the basis of the following criteria: review articles that did not report original results, species other than the rat, intracerebral drug administration alone, genetically manipulated rats, and animals having any kind of experimental pathology. The reported results indicate that the effect of drugs on the inhibitory avoidance task performed in the elevated T-maze and on the spatio temporal indexes of anxiety measured in the X and plus mazes correlate with their effect in patients diagnosed with generalized anxiety disorder. In contrast, the drug effects on the one-way escape task in the elevated T-maze predict the drug response of panic disorder patients. Overall, the drug effects assessed with the avoidance task in the T-maze are more consistent than those measured through the anxiety indexes of the X and plus mazes. Therefore, the elevated T-maze is a promising animal model of generalized anxiety and panic disorder.Keywords
This publication has 55 references indexed in Scilit:
- Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor proteinDepression and Anxiety, 2005
- Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-mazePharmacological Research, 2003
- Origin and functional role of the extracellular serotonin in the midbrain raphe nucleiBrain Research Reviews, 2002
- On the elevated plus-maze the anxiolytic-like effects of the 5-HT 1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT 1A partial agonist, buspirone, are blocked by the 5-HT 1A antagonist, WAY 100635Psychopharmacology, 1997
- The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviourJournal of Psychopharmacology, 1997
- Ethopharmacological analysis of rat behavior on the elevated plus-mazePharmacology Biochemistry and Behavior, 1994
- Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesionsPsychopharmacology, 1992
- Electrophysiological Investigation of the Adaptive Response of the 5-HT System to the Administration of 5-HT1A Receptor AgonistsJournal of Cardiovascular Pharmacology, 1990
- Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptorsPsychopharmacology, 1987
- The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus LorazepamPharmacopsychiatry, 1985